Skip to main content
CL
NYSE Industrial Applications And Services

Colgate Q3 Beats: EPS $0.94, Gross Margin Up 80 bps, Full-Year EPS Guidance Raised to 5-7%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Household Product Stocks · Consumer
Sentiment info
Positive
Importance info
7
Price
$96.14
Mkt Cap
$74.265B
52W Low
$74.545
52W High
$99.33
52W Position info
29% above low
Off High info
3.2% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

CL sits 29% above its 52-week low of $74.545.

Summary

Colgate's third quarter delivered 4.6% net sales growth and 80 basis points of gross margin expansion, alongside a raised full-year EPS growth outlook of 5% to 7%.


Key Events · Earnings and Guidance · CL

  • Q3 Sales and EPS Growth

    Net sales rose 4.6% to $5,369 million, and GAAP diluted EPS rose 3% to $0.94; Base Business EPS rose 7% to $0.97.

  • Gross Margin Expansion

    GAAP gross profit margin increased 80 basis points to 60.2%, and Base Business gross margin rose 90 basis points to 60.3%, helped by pricing and the exit from lower-margin private label pet food.

  • Full-Year Guidance Raised

    Base Business EPS growth guidance was raised to 5% to 7% from mid-single-digit, gross margin is now expected up versus roughly flat, and net sales guidance was narrowed to up 4% to 5% from 2% to 6%.

  • Advertising Investment Increased

    Advertising spending rose to $775 million from $674 million, a double-digit increase supporting brand investment.


Analysis · CL · Industrial Applications And Services

The margin story is the real news here: GAAP gross profit margin rose 80 basis points to 60.2% even as advertising spending jumped to $775 million from $674 million. Net sales grew 4.6% to $5,369 million, with organic sales up 3.6%. Management raised full-year Base Business EPS growth guidance to 5% to 7% from mid-single-digit and now expects gross profit margin to be up rather than roughly flat, while narrowing the sales range to 4% to 5%. For a defensive staple trading near its 52-week high, the raised profit outlook supports the earnings trajectory rather than changing the thesis.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CL was trading at $96.14 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $74.3B. The 52-week trading range was $74.55 to $99.33. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CL - Latest Insights

CL
Oct 30, 2026, 6:55 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $94.00
Real-time Price: $101.04 info
Change: +$7.04 (+7%) info
Market Cap: $80.347B info
CL
Jul 31, 2026, 10:13 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $91.04
Real-time Price: $101.04 info
Change: +$10.01 (+11%) info
Market Cap: $80.347B info
CL
Jul 31, 2026, 8:32 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $89.95
Real-time Price: $101.04 info
Change: +$11.09 (+12%) info
Market Cap: $80.347B info
CL
Jul 31, 2026, 8:21 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $90.00
Real-time Price: $101.04 info
Change: +$11.04 (+12%) info
Market Cap: $80.347B info
CL
Jul 31, 2026, 7:58 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $90.00
Real-time Price: $101.04 info
Change: +$11.04 (+12%) info
Market Cap: $80.347B info